Health Care/Hospital News & Press Release Distribution

ASEAN and CGIAR Launch Joint Program on Accelerating Innovation in Agri-Food Systems

KUALA LUMPUR, Malaysia, Oct. 17, 2023 /PRNewswire/ -- The ASEAN-CGIAR Innovate for Food and Nutrition Security Regional Program was officially launched during the 45th Meeting of the ASEAN Ministers on Agriculture and Forestry (AMAF) in Kuala Lumpur, Malaysia on October 4, 2023. This program aims ...

2023-10-17 11:49 1554

ASEAN and CGIAR Launch Joint Program on Accelerating Innovation in Agri-Food Systems

Docquity pioneers the first regional job platform focused on Southeast Asia's healthcare professionals

* Docquity Jobs enables healthcare organizations to access the region's largest database of medical talent across different specialities * In just one year, the job portal has expanded to four countries with around 400 employers on board * Docquity Jobs has seen a 30% month-on-month growth...

2023-10-17 10:00 1772

Docquity pioneers the first regional job platform focused on Southeast Asia's healthcare professionals

Docquity unveils Southeast Asia's first regional job portal tailored for healthcare professionals

* Docquity Jobs enables healthcare organizations to access the region's largest database of medical talent across different specialities * In just one year, the job portal has expanded to four countries with around 400 employers on board * Docquity Jobs has seen a 30% month-on-month growth...

2023-10-17 10:00 1790

Docquity introduces the first regional job portal dedicated to healthcare professionals in Southeast Asia

* Docquity Jobs enables healthcare organizations to access the region's largest database of medical talent across different specialities * In just one year, the job portal has expanded to four countries with around 400 employers on board * Docquity Jobs has seen a 30% month-on-month growt...

2023-10-17 10:00 1383

WuXi Biologics Launches New High-Productivity Bioprocessing Platform WuXiUI™ for Cost-Effective Commercial Manufacturing and Desirable Product Quality

* WuXiUI™ ultra-intensified fed-batch platform offers a new process option for maximum flexibility to meet various clients' needs in biologics development and manufacture. The platform can significantly improve productivity and quality, and reduce cost-of-goods (COGS) in commercial manufacturin...

2023-10-17 08:30 1298

World Health Organization Presents Global Action Plan for Neurological Disorders at World Congress of Neurology

MONTREAL, Oct. 16, 2023 /PRNewswire/ -- The World Health Organization (WHO) revealed its new Intersectoral Global Action Plan (IGAP), a critical blueprint for combating neurological conditions that calls for urgent action from governments and health care organizations around the world. IGAP outli...

2023-10-16 22:50 1400

Chamlion Partners with GPAINNOVA to Accelerate the Digitization of Dental Industry

SHANGHAI, Oct. 16, 2023 /PRNewswire/ -- On October 15th, Chamlion and global surface metal finishing expert GPAINNOVA signed a strategic cooperation agreement. Chamlion will become GPAINNOVA's exclusive dental strategic partner inChina. The two companies will establish a joint venture in China to...

2023-10-16 22:27 1252

Chamlion Partners with GPAINNOVA to Accelerate the Digitization of Dental Industry

Abbisko will debut two blockbuster clinical research results at the 2023 European Society for Medical Oncology（ESMO）

SHANGHAI, Oct. 16, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter) announced that the clinical results of first-in-human study of FGFR4 inhibitor Irpagratinib（ABSK011）and the clinical results of first-in-human dose-escalating of PD-L1 inhibitor ABSK043 with...

2023-10-16 21:50 1423

New Study Demonstrates Lunit SCOPE IO's Effectiveness to Predict Biliary Tract Cancer Therapy Outcomes - Findings to be Presented at the ESMO 2023

- Nine abstracts, featuring the effectiveness of Lunit's AI-powered TIL/WSI analyzer and biomarker platform, accepted by the ESMO 2023 Congress SEOUL, South Korea, Oct. 16, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeut...

2023-10-16 21:10 1288

New Study Demonstrates Lunit SCOPE IO's Effectiveness to Predict Biliary Tract Cancer Therapy Outcomes - Findings to be Presented at the ESMO 2023

Hong Kong Breast Cancer Foundation - "Pink Walk 2023" Charity Walk Concluded Successfully

Nearly 2,000 Pink Walkers returned to the Peak for Step Up for Breast Health HONG KONG, Oct. 16, 2023 /PRNewswire/ -- The annual flagship fundraising event, "Pink Walk 2023" organised by the Hong Kong Breast Cancer Foundation (HKBCF), was successfully held on 15 October in the Breast Cancer Aware...

2023-10-16 21:01 1554

TaiMed Announces Significant Progress in Clinical Trials for New HIV Treatment

Company champions long-acting HIV therapy with new biologic drug TMB-365/380 combination; after favorable results of Phase1b/2a, company plans to accelerate Phase 2 clincial study to expedite path to market TAIPEI, Oct. 16, 2023 /PRNewswire/ -- TaiMed Biologics

2023-10-16 21:00 1181

TaiMed Announces Significant Progress in Clinical Trials for New HIV Treatment

I-Mab Announces Phase 1 Data of Givastomig at ESMO 2023

ROCKVILLE, Md. and SHANGHAI, China, Oct. 16, 2023 /PRNewswire/ -- I-Mab (Nasdaq: IMAB) (the "Company"), a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapie...

2023-10-16 20:00 1315

SeekIn Presents New Validation Studies of OncoSeek Multi-cancer Early Detection test at Early Detection of Cancer Conference in London

Two Sample Types, Three Different Platforms, Five Independent Cohorts of ~10,000 Cancer Patients and Non-cancer Individuals with Diverse Ethnic Backgrounds Validate OncoSeek's Ability to Detect Multiple Cancer Types and Predict Tissue of Origin of Cancers SHENZHEN, China, Oct. 16, 2023 /PRNewswi...

2023-10-16 20:00 1089

Abbisko presented two preclinical research results at the 35th International Molecular Targets and Cancer Treatment Conference (EORTC-NCI-AACR)

SHANGHAI, Oct. 16, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko" hereafter) announced that the results of the company's two preclinical studies published at the 35th International Molecular Targets and Cancer Treatment Conference (EORTC) be held inBoston, U.S.. These two research...

2023-10-16 18:20 1268

Fapon and Halodoc Forge Strategic Partnership to Drive the Development of Indonesia's In-Vitro Diagnostics Industry

JAKARTA, Indonesia, Oct. 16, 2023 /PRNewswire/ -- On October 12th, 2023, Fapon, a leading life-science organization, signed a strategic cooperation agreement with Halodoc, the largest telehealth platform inIndonesia. This partnership brings together Fapon's expertise in in-vitro diagnostics (IVD)...

2023-10-16 15:29 1842

Fapon and Halodoc Forge Strategic Partnership to Drive the Development of Indonesia's In-Vitro Diagnostics Industry

CANbridge Announces Full Enrollment Reached in the Core Part of The CAN103 Phase 2 Trial for Gaucher Disease in China

BEIJING and BURLINGTON, Mass., Oct. 16, 2023 /PRNewswire/ -- CANbridge Pharmaceuticals Inc. (1228.HK),a global biopharmaceutical company, with a foundation in China, committed to the research, development and commercialization of transformative therapies to treat rare disease and rare oncology, ...

2023-10-16 13:38 1100

World Health Summit kicks off in Berlin

Experts from around the world meet at the most important forum on global health BERLIN, Oct. 16, 2023 /PRNewswire/ -- The World Health Summit 2023, the world's leading meeting for global health, began Sunday morning inBerlin. From October 15 to 17, international representatives from politics, sci...

2023-10-16 10:50 1325

Ascentage Pharma and AstraZeneca Enter into Clinical Collaboration on the Registrational Phase III Study of Bcl-2 Inhibitor Lisaftoclax in Combination with BTK Inhibitor Acalabrutinib in Treatment-Naïve Patients with First-Line CLL/SLL

SUZHOU, China, and ROCKVILLE, Md., Oct. 15, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has entered into a clinical collaboration ...

2023-10-16 09:23 1781

Sozo Aesthetic Clinic, Raffles Place in Singapore, Introduces Updated Scars Treatment Protocol

SINGAPORE, Oct. 16, 2023 /PRNewswire/ -- Sozo Aesthetic Clinic is launching an updated acne scar treatment program for modern busy professionals inSingapore. DrJustin Boey, Medical Director, explains more about acne scars treatments in Singapore

2023-10-16 09:01 1434

Everest Medicines' Licensing Partner Pfizer Announces U.S. FDA Approves Etrasimod for Adults with Moderately to Severely Active Ulcerative Colitis

SHANGHAI, Oct. 16, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its licensing partner, Pfizer Inc. (NYSE: PFE) has received approval from the U.S. Food and Drug Administration (FDA) for VELSIPITY™ (etrasimod), an oral, once-daily, selective sphingosine-1-phosphate (...

2023-10-16 07:48 941